Authorised Prescriber Mentorship Program
For Psychiatrists Prescribing MDMA and Psilocybin-Assisted Therapy
Program Overview
This mentorship program is a monthly membership comprising a structured pathway designed for psychiatrists who have received TGA Authorised Prescriber (AP) status for MDMA and/or psilocybin. It provides clinical scaffolding, expert supervision, and a national and international peer network to ensure ethical and evidence-based psychedelic prescribing.
Aims of the Program
✔️ To support Authorised Prescribers and their teams and ensure safe and supported rollout of psychedelic-assisted therapy, consistent with TGA, HREC and RANZCP guidelines on prescribing psychedelic medicines.
✔️ To foster reflective, trauma-informed clinical practice
✔️ To encourage practice improvement
✔️ To build capacity through consistent and structured supervision, shared learning, and accountability
✔️ To encourage consistency in care quality across Authorised Prescribers in Australia
Who Is It For?
Psychiatrists with TGA Authorised Prescriber status for MDMA or psilocybin, or in the process of applying
Clinicians seeking structured support in developing their psychedelic practice
Program Structure
Duration:
Minimum 3 months apprenticeship. Commence anytime and cancel with a month's notice.
Includes per month:
1 x individual supervision with a psychiatrist supervisor
2 x group supervision sessions with a psychiatrist supervisor
On-call clinical and regulatory support
Access to additional supervision as required
Monthly professional development webinars
Webinars from diverse speakers and therapists on a range of topics:
Onboarding to the mentorship model
Legal, ethical, and reporting frameworks
Protocol design, HREC applications, understanding informed consent
Medication tapering
Preparation and integration psychotherapy models and approaches
Working in a therapeutic dyad and with multidisciplinary teams
Webinars from Australian and International experts
Supervision of supervision - guidance for authorised prescribers supervising therapist teams
Monthly Webinar Learning Circles
Facilitated, confidential case discussions
Thematic topics (e.g., working with trauma, managing transference, integrating spiritual experiences)
Dyad and Team Collaboration
Guidance on building and managing multidisciplinary teams
Guidance on working in therapeutic dyads
Access to a directory of trained psychologists and therapists
Co-therapy with an experienced psychedelic assisted therapist
Clinical Resources & Templates
Consent forms, screening checklists, treatment agreements
Risk management guides, adverse event protocols
Preparation and Integration tools
benefits
☑️ Expert mentorship from senior psychedelic prescribers
☑️ Reduced risk of practitioner isolation and burnout
☑️ Confidence in navigating clinical grey areas
☑️ Ethical accountability and peer support
☑️ Nationally aligned standards of care
Our lead supervisors are experienced Psychiatrists and Clinical Psychologists with experience in providing psilocybin assisted therapy for depression and/or MDMA assisted therapy for PTSD:
Monica Schweickle
Clinical Psychologist MAPS FCCLP MAAPi
Dr Simon Amar
FRANZCP
Dr Jonathan Starke
FRANZCP